Table 3.
ORs and 95% CIs of each variable versus respiratory symptoms, respiratory diseases and subject classification
Cougha | Sputumb | Any respiratory symptomc | Normal lung function without symptomd | |
---|---|---|---|---|
Former smoker | 0.8 (0.3, 2.6) | 1.7 (0.5, 5.3) | 1.0 (0.3, 2.8) | 0.9 (0.3, 2.5) |
Current smoker | 4.3 (1.5, 12.0)** | 5.0 (1.9, 13.3) ** | 4.9 (2.0, 11.8) *** | 0.3 (0.1, 0.6) ** |
Former marijuana user | 0.7 (0.3, 2.1) | 0.6 (0.2, 1.7) | - | - |
Current marijuana user | 1.5 (0.5, 4.6) | 1.3 (0.5, 3.5) | - | - |
White | 1.1 (0.4, 3.5) | - | - | - |
On HAART | 5.5 (1.4, 21.5)* | - | 2.7 (0.9, 8.1) | - |
Undetectable viral load | 0.3 (0.1, 0.9)* | - | - | - |
All the results were from multiple logistic regression analysis. Non-smoker group was the reference group in all the analysis. Reference group for other variables was non-marijuana user, non-white subject, subject who was not on HAART and subject who had detectable viral load respectively.
- The variable had p > 0.2 in uni-variate analysis and was not selected into multiple logistic regression analysis.
*p < 0.05 for the OR. ** p < 0.01 for the OR. *** p < 0.001 for the OR.
a Subject having no cough was reference group. Nagelkerke R2 = 0.252.
bSubject having no sputum was reference group. Nagelkerke R2 = 0.177.
cSubject having no respiratory symptom at all was reference group. Respiratory symptom was defined as cough, sputum or breathlessness. Nagelkerke R2 = 0.194.
d Subject having either abnormal lung function or any respiratory symptom was reference group. Abnormal lung function was defined as either FEV1/FVC < 70% or %FEV1<80% or %FVC < 80%, either pre- or post-salbutamol test. Nagelkerke R2 = 0.128.